Boryung Corporation (KRX: 003850)

Market Cap	688.30B
Revenue (ttm)	928.72B
Net Income (ttm)	64.58B
Shares Out	65.87M
EPS (ttm)	979.10
PE Ratio	10.67
Forward PE	10.47
Dividend	100.00 (0.95%)
Ex-Dividend Date	Dec 27, 2024

Volume	342,888
Open	10,430
Previous Close	10,550
Day's Range	10,140 - 10,580
52-Week Range	9,190 - 13,750
Beta	0.63
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, diabetes, central nervous system, and oncology drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 1,533
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003850

Financial Performance

In 2023, Boryung's revenue was 859.63 billion, an increase of 13.04% compared to the previous year's 760.48 billion. Earnings were 40.20 billion, a decrease of -4.04%.